Y-Biologics Competitors and Similar CompaniesClear all
G1 Therapeutics's competitors and similar companies include Immunomedics.
 G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. |  Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. | |
Founding Date | Founding Date 2008 | Founding Date 1982 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Durham, US HQ | Locations Morris Plains, US HQ |
Employees | Employees 17015% increase | Employees 8914% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $82.5m (FY, 2023) | Revenue (est.) $295k (FY, 2019) |
Cost of goods | Cost of goods $7.2m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $75.3m (FY, 2023) | Gross profit $295k (FY, 2019) |
Net income | Net income ($48m) (FY, 2023) | Net income ($357.3m) (FY, 2019) |
Operating ⚠ | ||
Patents (US) | Patents (US) 40 (FY, 2020) | Patents (US) 405 (Sep, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 289.6m | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Immunomedics
HQ
Morris Plains, US
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
View company